Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
OTLK compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
OTLK
Outlook Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
OTLK
Outlook Therapeutics, Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only OTLK
1
COR
Cencora
supplier
Shared
0
No shared counterparties.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
Role chip = supplier or customer
Source: SEC EDGAR
8 more · AMGN chain
›
OTLK
Outlook Therapeutics, Inc.
Change
0.44
· pre 0.44
· delayed
Mkt cap
$106.9M
Revenue
$8,700
Q3 FY26
Revenue
—
AMGN
Amgen Inc
Change
461.49
· pre 448.01
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Pre-market
Nov 6 '26
delayed
OTLK
Outlook Therapeutics, Inc.
vs
AMGN
Amgen Inc
0.44
pre 0.44
delayed
Price
461.49
pre 448.01
delayed
$106.9M
Mkt cap
$249.0B
Q3 FY26
$8,700
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
OTLK
0.44
vs
AMGN
461.49
Pre-market
Nov 6 '26
delayed